$5.060
+0.364 (+7.20%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TRDA Prediction & Forecast by Similar Chart Analysis
Alphio's TRDA stock price prediction model matches the current Entrada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.96 (-1.94%). The 1-week path is $4.91 (-2.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Entrada Therapeutics Inc Stock?
Entrada Therapeutics Inc is not a strong buy right now due to significant financial losses and declining revenues. The current price is $5.11, and the company reported a net loss of $42.76 million for Q2 2026, indicating ongoing financial struggles. Additionally, insider selling has increased by 1842.13% over the last month, suggesting a lack of confidence from company insiders. The RSI is at 60.02, indicating a neutral momentum, but the forward P/E ratio is extremely high at 3333.33, reflecting uncertainty about future earnings. The main risk is the company's declining cash reserves, which fell from $295.7 million to $223 million in just six months, indicating tightening operational cash flow.
TRDA stock price ended at $5.06 on Wednesday, after rising +7.20%
Entrada Therapeutics Inc (TRDA) last closed at $5.0599999, gaining +7.20%. These facts feed the 1-day and 1-week TRDA price prediction above.
Forecast Drivers
Entrada Therapeutics Inc (TRDA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TRDA, ranked by similarity.
Seasonality analysis for TRDA
Historically the probability of a positive November return for TRDA is 46.51%. January offers the highest probability of a positive month at 50.82%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TRDA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $3.17 | $3.97 | $4.59 | -21.51% |
| Dec 2026 | $3.50 | $3.76 | $4.40 | -25.64% |
In 2026, Entrada Therapeutics Inc (TRDA) is projected to range from $3.17 to $4.59.
Entrada Therapeutics Inc 2026 monthly forecast
In Nov 2026, Entrada Therapeutics Inc is projected to average $3.97, with a low of $3.17 and high of $4.59.
In Dec 2026, Entrada Therapeutics Inc is projected to average $3.76, with a low of $3.50 and high of $4.40.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.